PTC Therapeutics, Inc. (PTCT)
PTC Therapeutics (PTCT) sees significant social media buzz with a 362.73% surge in social dominance this week. Despite recent FDA setbacks, positive analyst sentiment and increased social activity are supporting the stock near its 52-week high.
About PTC Therapeutics, Inc.
PTC Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for rare diseases.
PTC Therapeutics, Inc. uses the ticker $PTCT for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- PTC Therapeutics, Inc. (PTCT) social dominance is up 362.73% from the previous week.
- PTC Therapeutics, Inc. (PTCT) creators is up 24.78% from the previous month.
- PTC Therapeutics, Inc. (PTCT) engagements is up 128.52% from the previous week.
- PTC Therapeutics, Inc. (PTCT) mentions is up 11.11% from the previous week.
- PTC Therapeutics, Inc. (PTCT) posts created is up 100% from the previous week.
Price: $69.20
Price 24-Hour Time-Series Raw Data
The stock price is near its 52-week high, supported by positive analyst sentiment and increased social media activity, which are currently outweighing negative news regarding the FDA's rejection of Vatiquinone.
24-Hour: -0.36% 7-Day: -4.12% 30-Day: -4.57%
1-Year High: $86.30 on 2025-11-26
1-Year Low: $36.20 on 2025-05-06
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
PTC Therapeutics, Inc. (PTCT) is currently AltRank #1,000 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [-----] [------]
[--] Month: [-----] +421
[--] Months: [-----] +545
[--] Year: [-----] [---]
1-Year High: [-----] on 2026-02-12
1-Year Low: [--] on 2025-09-13
Galaxy Score: [--]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] +8
[--] Year: [--] +2
1-Year High: [--] on 2025-06-23
1-Year Low: [--] on 2026-01-27
Engagements: [---] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [------] +129%
[--] Month: [------] +8.10%
[--] Months: [-------] -43%
[--] Year: [---------] +4.30%
1-Year High: [------] on 2025-07-28
1-Year Low: [---] on 2026-02-08
Engagements by network (24h): TikTok: [--] Reddit: [--] YouTube: [--] Instagram: [--] News: [--] X: [---]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +11%
[--] Month: [---] -0.44%
[--] Months: [-----] -36%
[--] Year: [-----] +46%
1-Year High: [---] on 2025-06-30
1-Year Low: [--] on 2026-01-02
Mentions by network (24h): TikTok: [--] Reddit: [--] YouTube: [--] Instagram: [--] News: [--] X: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning PTC Therapeutics, Inc. (PTCT) in the last [--] hours which is up 54% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [--] +19%
[--] Month: [---] +25%
[--] Months: [---] -55%
[--] Year: [-----] +68%
1-Year High: [---] on 2025-06-30
1-Year Low: [--] on 2025-10-12
The most influential creators that mention PTC Therapeutics, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Quantumup1 | [--] | [-----] | [--] | [--] |
| @MarcJacksonLA | [--] | [-----] | [--] | [--] |
| @PrometeusCT | [--] | [---] | [--] | [--] |
Sentiment: 44%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 44%
Daily Average: 82%
[--] Week: 50% -50%
[--] Month: 43% -49%
[--] Months: 43% -25%
[--] Year: 43% -34%
1-Year High: 100% on 2025-03-25
1-Year Low: 14% on 2025-04-12
Most Supportive Themes:
- Positive Analyst Ratings and Price Targets: (35%) Analysts are issuing positive ratings and price targets for PTCT, indicating potential for stock price appreciation.
- Mentions in AI and Momentum Stock Screeners: (30%) PTCT is being recognized in AI-driven stock rankings and momentum screeners, suggesting favorable technical and fundamental indicators.
- Inclusion in Biotech Stock Lists: (15%) The company is being highlighted in lists of strong biotech stocks, reflecting positive sentiment within the broader biotechnology sector.
Most Critical Themes:
- FDA Complete Response Letter for Vatiquinone: (40%) The FDA has issued a Complete Response Letter for Vatiquinone, citing insufficient efficacy, which is a significant negative development.
Social Dominance: 0.00583%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00583%
Daily Average: 0.00899%
[--] Week: 0.00509% +0.00399%
[--] Month: 0.0054% +0.0022%
[--] Months: 0.0054% -0.014%
[--] Year: 0.0054% -0.0073%
1-Year High: 0.046% on 2025-03-29
1-Year Low: 0.0019% on 2025-10-12
Market Dominance: 0.0063%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0063%
Daily Average: 0%
1-Year High: 0.277% on 2026-02-06
1-Year Low: 0.00485% on 2025-05-08
Market Cap: $5,553,542,057
Market Cap 24-Hour Time-Series Raw Data
Current Value: $5,553,542,057
Daily Average: $4,832,770,178
[--] Week: $5,553,542,057 -4.10%
[--] Month: $5,553,542,057 -4.60%
[--] Months: $5,553,542,057 +43%
[--] Year: $5,553,542,057 +64%
1-Year High: $6,924,866,306 on 2025-11-26
1-Year Low: $2,868,311,518 on 2025-05-06
Top PTC Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"📌 Biotech Stock News 2/13 @ Open $IMUX 26% $400M Private Placement $EVMN 14% $125M Private Placement $ANRO 5% Completion of Ph2 Study ALTO-101 $EBS 3% sNDA Approval for NARCAN Nasal Spray $GLTO 2% Closing of Public Offering $AZN 1% Results from KALOS and LOGOS trials $PTCT 0% Regulatory Update on Translarna $ITRM -5% Business Update $CHRS -13% Pricing of Public Offering $OKYO -25% Pricing of $20M Offering See the image and comments for more details 👇 https://twitter.com/i/web/status/2022352228829532451 https://twitter.com/i/web/status/2022352228829532451"
X Link @BiopharmIQ 2026-02-13T16:48Z 28.9K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing